...
首页> 外文期刊>The Professional Medical Journal >COMPARISON OF EFFICACY OF FERROUS SULPHATE WITH IRON POLYMALTOSE COMPLEX FOR TREATMENT OF IRON DEFICIENCY ANEMIA.
【24h】

COMPARISON OF EFFICACY OF FERROUS SULPHATE WITH IRON POLYMALTOSE COMPLEX FOR TREATMENT OF IRON DEFICIENCY ANEMIA.

机译:硫酸亚铁与聚麦芽糖醇配合物治疗缺铁性贫血疗效比较。

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Objective: To compare the efficacy of Ferrous sulfate with iron polymaltose complex in treatment of iron deficiency anemia in children in terms of rise in hemoglobin. Study design: Randomized clinical trial. Setting: Department of Paediatric Medicine Unit I Allied Hospital Faisalabad. Study duration: 6 months. Methodology: All the children of age group 6 month to 12year with hemoglobin level 10g/dl, MCV70fl corrected for age, MCHC32%, serum ferritin8μg/l were included. All other cases of anemia other than iron deficiency anemia such as thalassemia, sickle cell anemia, lead poisoning etc, patients with severe anemia (hb≤6g/dl) because they need blood transfusion to correct anemia, those with decompensated heart failure or acute infection were excluded. After enrolment patients were randomly divided into two groups by lottery method. Group A, patients were given ferrous sulphate. Group B, patients were given iron polymaltose complex (IPC). Both iron preparations were given in the dose of 5mg/kg/day of elemental iron in three divided dosage 30 minutes before meals. Patients were assessed at one month interval after the start of treatment and hemoglobin was checked at follow up visit by taking 2cc blood. Results: Sixty children were studied. Mean age was 2.5 ± 5.1 years, range 7 months to 12 years with 32 girls, 28 boys. The patients were evenly distributed between the two treatment groups (IPC, n = 30, 50%; ferrous sulfate, n = 30, 50%). All erythrocyte-related hematologic parameters after one month treatment showed a significant improvement from baseline with both treatments. A significant improvement in Hb was observed after one month treatment in the IPC group 9.5 ± 1.1g/dL to 10.6 ±1.0 g/dL and the ferrous sulfate group 9.4 ± 1.6 g/dL to 11.2 ± 0.9 g/dL which was statistically significant. Conclusion: From this randomized study, it is concluded that both ferrous sulphate and iron polymaltose complex have equal efficacy in treatment of iron deficiency anemia.
机译:目的:从血红蛋白升高的角度比较硫酸亚铁与聚麦芽糖铁复合物治疗儿童缺铁性贫血的疗效。研究设计:随机临床试验。地点:费萨拉巴德联合医院儿科第一科。研究时间:6个月。方法:所有年龄在6个月至12岁之间的儿童,其血红蛋白水平<10g / dl,校正后的MCV <70fl,MCHC <32%,血清铁蛋白<8μg/ l。除铁缺乏性贫血以外的所有其他贫血病例,例如地中海贫血,镰状细胞性贫血,铅中毒等;重度贫血(hb≤6g/ dl)的患者,因为他们需要输血来纠正贫血,失代偿性心力衰竭或急性感染被排除在外。入选后,通过抽签方法将患者随机分为两组。 A组患者接受硫酸亚铁治疗。 B组患者接受了铁多麦芽糖复合物(IPC)治疗。餐前30分钟,两种铁制剂均以5mg / kg /天的元素铁的剂量分三批服用。在开始治疗后的一个月间隔对患者进行评估,并在随访期间通过服用2cc血液检查血红蛋白。结果:研究了60名儿童。平均年龄为2.5±5.1岁,范围为7个月至12岁,其中32位女孩,28位男孩。患者平均分布在两个治疗组之间(IPC,n = 30,50%;硫酸亚铁,n = 30,50%)。在两个月的治疗后,所有与红细胞相关的血液学参数均显示出相对于基线的显着改善。在IPC组9.5±1.1 g / dL至10.6±1.0 g / dL和硫酸亚铁组9.4±1.6 g / dL至11.2±0.9 g / dL治疗一个月后,Hb明显改善。 。结论:从这项随机研究得出的结论是,硫酸亚铁和聚麦芽糖铁复合物在治疗缺铁性贫血方面具有相同的疗效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号